623: Four Year Prostate Specific Antigen (PSA) Progression and Prostate Cancer Detection in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Section Rotterdam

Abstract

You have accessJournal of UrologyDiscussed Poster, Sunday, May 9, 2004, 1:00 - 5:00 pm1 Apr 2004623: Four Year Prostate Specific Antigen (PSA) Progression and Prostate Cancer Detection in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Section Rotterdam Rene Raaijmakers, Fritz H. Schroder, Stijn H. De Vries, and Monique J. Roobol Rene RaaijmakersRene Raaijmakers More articles by this author , Fritz H. SchroderFritz H. Schroder More articles by this author , Stijn H. De VriesStijn H. De Vries More articles by this author , and Monique J. RoobolMonique J. Roobol More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)37885-6AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "623: Four Year Prostate Specific Antigen (PSA) Progression and Prostate Cancer Detection in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Section Rotterdam." The Journal of Urology, 171(4S), p. 166 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 171Issue 4SApril 2004Page: 166 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Rene Raaijmakers More articles by this author Fritz H. Schroder More articles by this author Stijn H. De Vries More articles by this author Monique J. Roobol More articles by this author Expand All Advertisement PDF downloadLoading ...